Search

Find uplifting stories about heroes, innovations, and solutions

5 results for "massachusetts general hospital"

Stage 3 Pancreatic Cancer Survivor Runs Boston Marathon
Community Heroes1d ago

Stage 3 Pancreatic Cancer Survivor Runs Boston Marathon

Ray Angelone, 57, is running his fourth Boston Marathon, but this time as a Stage 3 pancreatic cancer survivor. After successful treatment at Mass General Hospital, he's returning to the race to support the team that saved his life.

Google News - Cancer Survivor2 min read
Cancer Survivor, 22, Runs Boston Marathon for MGH Doctors
Health & WellnessApr 5

Cancer Survivor, 22, Runs Boston Marathon for MGH Doctors

Grace Taylor was 19 when doctors found aggressive thyroid cancer wrapped around her vocal cords and spreading to her skull. Three years later, she's running 26.2 miles to thank the team that saved her life.

Google News - Cancer Survivor2 min read
Mass General Tests Therapy Coaches for Ketamine Treatment
Health & WellnessApr 1

Mass General Tests Therapy Coaches for Ketamine Treatment

Massachusetts General Hospital just launched a clinical trial to find out if adding a human "coach" during ketamine therapy makes the treatment work better for depression. The study could reshape how millions access mental health care.

STAT News2 min read
Two-Time Cancer Survivor Runs Boston for Mass General
Community HeroesMar 19

Two-Time Cancer Survivor Runs Boston for Mass General

Kevin O'Rourke will run his first marathon since beating cancer twice, honoring both his late father and the hospital that gave them both more time. The 57-year-old principal returns to Boston's iconic race 27 years after his last run.

Google News - Cancer Survivor2 min read
New OCD App Shows 65% Success Rate in Mass General Trial
SolutionsJan 26

New OCD App Shows 65% Success Rate in Mass General Trial

A smartphone app developed at Massachusetts General Hospital is helping people with OCD access effective treatment without the cost, stigma, and scheduling barriers of traditional therapy. In a 12-week trial, 65% of users saw significant symptom reduction, and 91% would recommend it to a friend.

Medical Xpress3 min read